Bellevue Life Sciences Acquisition Corp. Warrant
Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquire companies in the healthcare industry. The company was founded in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp… Read more
Bellevue Life Sciences Acquisition Corp. Warrant (BLACW) - Total Assets
Latest total assets as of June 2024: $20.63 Million USD
Based on the latest financial reports, Bellevue Life Sciences Acquisition Corp. Warrant (BLACW) holds total assets worth $20.63 Million USD as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Bellevue Life Sciences Acquisition Corp. Warrant - Total Assets Trend (2020–2023)
This chart illustrates how Bellevue Life Sciences Acquisition Corp. Warrant’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Bellevue Life Sciences Acquisition Corp. Warrant - Asset Composition Analysis
Current Asset Composition (December 2023)
Bellevue Life Sciences Acquisition Corp. Warrant's total assets of $20.63 Million consist of 0.1% current assets and 99.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.0% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2023)
This chart illustrates how Bellevue Life Sciences Acquisition Corp. Warrant's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bellevue Life Sciences Acquisition Corp. Warrant's current assets represent 0.1% of total assets in 2023, a decrease from 19.4% in 2020.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2023, down from 19.4% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Bellevue Life Sciences Acquisition Corp. Warrant Competitors by Total Assets
Key competitors of Bellevue Life Sciences Acquisition Corp. Warrant based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
464680
KQ:464680
|
Korea | ₩31.23 Billion |
|
Cartesian Growth Corporation III Unit
NASDAQ:CGCTU
|
USA | $281.56 Million |
|
Azure Holding Group Corp
PINK:AZRH
|
USA | $16.92 Million |
|
Constellation Capital Corp.
V:CNST-P
|
Canada | CA$627.53K |
|
Little Fish Acquisition I Corp.
V:LILL-P
|
Canada | CA$56.48K |
|
Hana 30 Special Purpose Acquisition Company
KQ:469880
|
Korea | ₩17.89 Billion |
|
Chicane Capital I Corp.
V:CCIC-P
|
Canada | CA$199.07K |
|
Cuspis Capital II Ltd
V:CCII-P
|
Canada | CA$1.51 Million |
Bellevue Life Sciences Acquisition Corp. Warrant - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Bellevue Life Sciences Acquisition Corp. Warrant generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Bellevue Life Sciences Acquisition Corp. Warrant generates $ 1.10 in net profit.
Bellevue Life Sciences Acquisition Corp. Warrant - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.05 | 0.11 | 0.01 |
| Quick Ratio | 0.05 | 0.11 | 0.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-3.25 Million | $ -482.39K | $ -702.45K |
Bellevue Life Sciences Acquisition Corp. Warrant - Advanced Valuation Insights
This section examines the relationship between Bellevue Life Sciences Acquisition Corp. Warrant's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 2887.9% |
| Total Assets | $36.63 Million |
| Market Capitalization | $470.20 USD |
Valuation Analysis
Below Book Valuation: The market values Bellevue Life Sciences Acquisition Corp. Warrant's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Bellevue Life Sciences Acquisition Corp. Warrant's assets grew by 2887.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Bellevue Life Sciences Acquisition Corp. Warrant (2020–2023)
The table below shows the annual total assets of Bellevue Life Sciences Acquisition Corp. Warrant from 2020 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $36.63 Million | +2887.94% |
| 2022-12-31 | $1.23 Million | +73.86% |
| 2021-12-31 | $705.09K | +118.46% |
| 2020-12-31 | $322.75K | -- |